Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients - the BISHOP study.
Resende GG, da Cruz Lage R, Lobê SQ, Medeiros AF, Costa E Silva AD, Nogueira Sá AT, Oliveira AJA, Sousa D, Guimarães HC, Gomes IC, Souza RP, Aguiar RS, Tunala R, Forestiero F, Bueno Filho JSS, Teixeira MM.
Resende GG, et al. Among authors: forestiero f.
Infect Dis (Lond). 2022 Aug;54(8):591-599. doi: 10.1080/23744235.2022.2066171. Epub 2022 Apr 29.
Infect Dis (Lond). 2022.
PMID: 35485381
Clinical Trial.